01 Dec 2022 08:00 CET

Issuer

Benchmark Holdings plc

1 December 2022

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND
DEPENDENCIES, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA),
CANADA, AUSTRALIA, NEW ZEALAND, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF
THE PEOPLE'S REPUBLIC OF CHINA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA, OR ANY
OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.
Benchmark Holdings plc

(“Benchmark”, the “Company” or the “Group”)

First day in bookbuilding period for the Private Placement and application
period in Norwegian Retail Offering
and
Publication of Norwegian national prospectus

Reference is made to the stock exchange announcement yesterday, on 30 November
2022, whereby Benchmark announced the terms of the Private Placement and
Norwegian Retail Offering to be carried out in connection with the Company's
application for admission of the Company's shares on Euronext Growth Oslo (the
“Euronext Growth Admission”).

The national prospectus for the Norwegian Retail Offering including the
application forms for the retail offering has been registered with the Norwegian
Register of Business Enterprises, and will, subject to regulatory restrictions
in certain jurisdictions, be available at
www.benchmarkplc.com/investors/oslo-listing/ and on the websites of each of DNB
Markets, a part of DNB ASA at www.dnb.no/emisjoner and Pareto Securities AS at
www.paretosec.com/transactions. For regulatory reasons, investors in the United
Kingdom are not able to participate in the Norwegian Retail Offering.

The bookbuilding for the Private Placement and the application period for the
Norwegian Retail Offering will commence on 1 December 2022 at 09:00 hours (CET)
and end at 17:30 (CET) on 6 December 2022, both subject to shortening and
extensions at any time at the sole discretion of the Company.

The Company reserves the right, at any time and for any reason, to cancel,
and/or modify the terms of, the Private Placement. Neither the Company nor the
Managers will be liable for any losses incurred by applicants if the Private
Placement is cancelled, irrespective of the reason for such cancellation.

The capitalised terms used in this announcement have the meaning set out in the
“Private Placement and Retail Offering” announcement made by the Company at 7.01
a.m. GMT on 30 November 2022.

DNB Markets, a part of DNB Bank ASA and Pareto Securities AS have been engaged
as joint global coordinators and joint bookrunners (jointly the "Managers").
Advokatfirmaet Wiersholm AS and Travers Smith LLP are acting as legal counsel to
the Company (advising on Norwegian and English law, respectively), while
Advokatfirmaet BAHR AS is acting as legal counsel to the Managers.

Enquiries:

Via benchmark@mhpc.com to:

Chief Executive Officer
Trond Williksen

Chief Financial Officer
Septima Maguire

Investor Relations
Ivonne Cantu

MHP
Tel: + 44 20 3128 8004

Numis (Broker and NOMAD)
James Black, Freddie Barnfield, Duncan Monteith
Tel: +44 20 7260 1000

About Benchmark
Benchmark is a market leading aquaculture biotechnology company. Benchmark's
mission is to drive sustainability in aquaculture by delivering products and
solutions in genetics, advanced nutrition and health which improve yield, growth
and animal health and welfare. Through a global footprint in 26 countries and a
broad portfolio of products and solutions, Benchmark addresses the major
aquaculture species - salmon, shrimp, sea bass and bream, and tilapia, in all
the aquaculture regions around the world. Find out more at www.benchmarkplc.com.

Important Notice
Neither this announcement, nor any copy of it, may be taken or transmitted,
published or distributed, directly or indirectly, in or into the United States
or any other jurisdiction where to do so would constitute a violation of the
relevant securities laws of such jurisdiction. This announcement is for
information purposes only and does not constitute an offer to sell or issue, or
the solicitation of an offer to buy, acquire or subscribe for any shares in the
Company in the United States or any other state or jurisdiction in which such
offer or solicitation is not authorised or to any person to whom it is unlawful
to make such offer or solicitation. Any failure to comply with these
restrictions may constitute a violation of securities laws of such
jurisdictions.

The securities referred to in this announcement have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), or under the securities laws of any state or other jurisdiction of the
United States and may not be offered, sold, pledged or otherwise transferred,
directly or indirectly, within the United States, except pursuant to an
applicable exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act and in compliance with any applicable U.S.
state securities laws or other jurisdiction of the United States. There will be
no public offer of the securities referred to herein in the United States.

In any EEA Member State, this communication is only addressed to and is only
directed at qualified investors in that Member State within the meaning of the
Prospectus Regulation, i.e., only to investors who can receive the offer without
an approved prospectus in such EEA Member State. The expression "Prospectus
Regulation" means Regulation (EU) 2017/1129 as amended (together with any
applicable implementing measures in any Member State.

This communication is only being distributed to and is only directed at persons
in the United Kingdom that are (i) investment professionals falling within
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities,
falling within Article 49(2)(a) to (d) of the Order and other persons to whom
this announcement may lawfully be communicated (all such persons together being
referred to as "relevant persons"). This communication must not be acted on or
relied on by persons who are not relevant persons. Any investment or investment
activity to which this communication relates is available only for relevant
persons and will be engaged in only with relevant persons. Persons distributing
this communication must satisfy themselves that it is lawful to do so.

All offers of the New Shares in the United Kingdom will be made pursuant to an
exemption from the requirement to produce a prospectus under the UK Prospectus
Regulation.

Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as "believe", "expect", "anticipate",
"strategy", "intends", "estimate", "will", "may", "continue", "should" and
similar expressions. The forward-looking statements in this release are based
upon various assumptions, many of which are based, in turn, upon further
assumptions. Although the Company believe that these assumptions were reasonable
when made, these assumptions are inherently subject to significant known and
unknown risks, uncertainties, contingencies and other important factors which
are difficult or impossible to predict, and are beyond their control. Such
risks, uncertainties, contingencies and other important factors could cause
actual events to differ materially from the expectations expressed or implied in
this release by such forward-looking statements. The Company does not make any
guarantee that the assumptions underlying the forward-looking statements in this
announcement are free from errors nor does it accept any responsibility for the
future accuracy of the opinions expressed in this announcement or any obligation
to update or revise the statements in this announcement to reflect subsequent
events. You should not place undue reliance on the forward-looking statements in
this announcement.

The information, opinions and forward-looking statements contained in this
announcement speak only as at its date, and are subject to change without
notice. The Company does not undertake any obligation to review, update,
confirm, or to release publicly any revisions to any forward-looking statements
to reflect events that occur or circumstances that arise in relation to the
content of this announcement.

Neither the Manager nor any of its affiliates makes any representation as to the
accuracy or completeness of this announcement and none of them accepts any
responsibility for the contents of this announcement or any matters referred to
herein. This announcement is made by, and is the responsibility of, the Company.
The Managers and their affiliates are acting exclusively for the Company and
no-one else in connection with the transactions described in this announcement.
They will not regard any other person as their respective clients in relation to
the transactions described in this announcement and will not be responsible to
anyone other than Benchmark, for providing the protections afforded to their
respective clients, nor for providing advice in relation to the transactions
described in this announcement, the contents of this announcement or any
transaction, arrangement or other matter referred to herein.

This announcement is for information purposes only and is not to be relied upon
in substitution for the exercise of independent judgment. It is not intended as
investment advice and under no circumstances is it to be used or considered as
an offer to sell, or a solicitation of an offer to buy any securities or a
recommendation to buy or sell any securities of the Company. Neither the Manager
nor any of its affiliates accepts any liability arising from the use of this
announcement.

The distribution of this announcement and other information may be restricted by
law in certain jurisdictions. Persons into whose possession this announcement or
such other information should come are required to inform themselves about and
to observe any such restrictions.


Source

Benchmark Holdings plc

Provider

Oslo Børs Newspoint

Company Name

Benchmark Holdings Plc 22/25 FRN C

ISIN

NO0012704099

Market

Nordic Alternative Bond Market